insights_auto
Why is BOT down 5.26%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.018
arrow_downward
-5.26%(-0.0010) 1D
Oct 2, 5:10:22 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.02
High
A$0.02
Low
A$0.02
Mkt. cap
47.22M
Avg. vol.
6.30M
Volume
5.35M
52-wk high
A$0.17
52-wk low
A$0.02
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.02
High
A$0.02
Low
A$0.02
Mkt. cap
47.22M
Avg. vol.
6.30M
Volume
5.35M
52-wk high
A$0.17
52-wk low
A$0.02
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
Dealroom
·
18 minutes ago
Evernorth clears vote for $1B XRP treasury merger, Nasdaq debut set for October 8
Benzinga
·
51 minutes ago
S&P 500 Index Outlook: Top Catalysts for US Stocks This Week
AOL.com
·
9 hours ago
History Says Stocks Typically Fall After a Fed Hike Cycle Begins -- Then Gain 6.8% Within a Year. Here's My Plan.
24/7 Wall St.
·
10 hours ago
Why Pay to Own U.S. Stocks? This Zero-Fee ETF Is Beating the S&P 500
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd